The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation | MicrobiomeTrials
The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation
RecruitingPHASE1, PHASE2INTERVENTIONAL
Trial Details
Start: 2022-11-18Est. Completion: 2027-06-25
Enrollment target: 260 participants
Locations
City of Hope, Duarte, California, United States
National Institutes of Health Clinical Center, Bethesda, Maryland, United States